Member Info for jackdaw99

Given that I suspect the RTO will go through, and that I need to see a price of over £6 on my consolidated stock to see a return to b/e, I've decided to continue the gamble by trying to buy 5-10,000 (hopefully at 20p or less) in the new co ASAP on listing. The scientific possibilities look promising and it could bag 5-10x at some point in the near future - not at all unknown in the bio area - and not bother taking up any warrants until we see where it's heading. If it looks good, then I have another the warrants to pile in but no point initially if I can get them at 20p.

Interesting but I don't have 60 years!

.. is to vote to let the deal go through and take legal action afterwards. Perhaps someone with deeper pockets than myself could seek counsel?

Post. Read the RNS.

"Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market
November 26, 2019 02:00 ET | Source: Motif Bio plc "

"It clearly states warrants are post consolidation". Thanks but we knew that,

"Does anybody know what we would achieve by voting against the RTO? " There have been suggestions. Better terms would be everyone's first choice I suppose - in particular, ditch the 1/220 dilution. Less important are the warrants as they assume we small folk have the cash to buy them! The risks are that the co-party walks away, does something else, and makes billions, causing us all the cry into our beer. Obviously we want all our lost money back but new shareholders regard us as having backed a loser and don't want such generous terms. For myself I feel that, given that we backed a loser, the 1/220 is still too severe and that 1/50 would have been an appropriate dilution giving both sides some satisfaction. Each to his own obviously.

"Those other deals must of been tossed in the" Thanks but we knew that.

That would do me - 2.8$ billion applied to us would (back of envelope) be about £20 per share I think?

I asked the same question ..... but had no replies.

I think it's correct that there are 655 million (voting?) shares in issue currently. If I thought by voting NO my million shares would cause an improvement in the offer I would do it in a heartbeat. Unfortunately I don't think we have that power but I could be persuaded if momentum builds.

Port Authority buses best way to get into town. Airport to Grand Central and dead easy. Can't remember price but not expensive.

"If it is 2 warrants for every 1 current share price we will do very well. About 15 X but you will have to exercise them (Pay for them) " For crying out loud ...... BUT IT'S NOT!

The new co's technology looks promising and, with an initially low (for bio/pharma) valuation of £16m it is entirely possible that this could 10x if you are prepared to wait months or perhaps a couple of years. Possibly a lot more than 10x. Yes, backing Iclaprim was a failure and I will probably never get back to b/e of six quid a share in the new co (!), but there should be something ... which is better than nothing.

No offence intended.

Perhaps some one who understands these things should speak to them?

"If it is 2 warrants for every 1 current share pre-consolidation we are set to make 15x our money back at a price close to the final live price..." No you are not.

"I think this is where the kicker is. You need to BUY the shares for 0.30p " Jesus - did you not realise this - it's a WARRANT not a free gift. The past 24 hours has seen loads of posts explaining what a warrant is and you still don't get it?

Anyway, Walbrook's interpretation would be nice BUT it just doesn't tally with the number of warrants on offer. I'd rather believe the numbers for now than some spotty intern.

Yes, well worth listening.

I've had a look at the science today. There's certainly loads of potential in the approach generally but what caught my eye, given current trends, is that one of the diagrams implies that their technology could be used to enhance CAR-T technology currently being used to treat some cancers (with high success rates). If so, BVX may have a lot of interest from Novartis and many others once they prove the principle. The other interesting thing on the website is that, if you go to the Investor Relations section, it has the current share price listed as £100.12, so that's all good then! On the downside, they seem to have had a fair turnover of directors in their short life - why?
https://www.bivictrix.com/investor-centre/aim-26